Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Stock Valuation & Research

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

LIMN key statistics

Explore LIMN's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.